Schedule 13G ownership disclosure

ASTRIA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 04635X102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Fairmount Funds Management LLC

    Shares: 5,869,037.00 · Class: 9.9%

  • Fairmount Healthcare Fund II GP LLC

    Shares: 5,869,037.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014000
Form type
SCHEDULE 13G/A
Filer
Astria Therapeutics, Inc.
CIK
CIK 1454789
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub